Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
DNA Repair Pathway Stimulated by the Forkhead Transcription Factor FOXO3a Through the Gadd45 Protein
Hien Tran,1*Anne Brunet,1*Jill M. Grenier,2Sandeep R. Datta,1Albert J. Fornace Jr.,3Peter S. DiStefano,2Lillian W. Chiang,2Michael E. Greenberg1
The signaling pathway from phosphoinositide
3-kinase to the protein kinase Akt controls organismal life-span in
invertebratesand cell survival and proliferation in mammals by
inhibiting theactivity of members of the FOXO family of transcription
factors.We show that mammalian FOXO3a also functions at the
G2 to M checkpointin the cell cycle and triggers the
repair of damaged DNA. By genearray analysis, FOXO3a was found to
modulate the expression ofseveral genes that regulate the cellular
response to stress atthe G2-M checkpoint. The growth
arrest and DNA damage responsegene Gadd45a appeared to be a
direct target of FOXO3a that mediatespart of FOXO3a's effects on DNA
repair. These findings indicatethat in mammals FOXO3a regulates the
resistance of cells to stressby inducing DNA repair and thereby may
also affect organismallife-span.
1 Division of Neuroscience, Children's
Hospital and Department of Neurobiology, Harvard Medical School,
Boston, MA 02115, USA.
2 Millennium Pharmaceuticals,
Inc., 640 Memorial Drive, Cambridge, MA 02139, USA.
3 Building 37, Room 6144, NCI, National Institutes
of Health, 37 Convent Drive MSC 4255, Bethesda, MD 20892, USA.
*
These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail:
michael.greenberg{at}tch.harvard.edu
G. Li, Y.-F. Lee, S. Liu, Y. Cai, S. Xie, N.-C. Liu, B.-Y. Bao, Z. Chen, and C. Chang (2008)
Endocrinology
149, 3490-3499
|Abstract »|Full Text »|PDF »
Nuclear HuR accumulation through phosphorylation by Cdk1.
H. H. Kim, K. Abdelmohsen, A. Lal, R. Pullmann Jr., X. Yang, S. Galban, S. Srikantan, J. L. Martindale, J. Blethrow, K. M. Shokat, et al. (2008)
Genes & Dev.
22, 1804-1815
|Abstract »|Full Text »|PDF »
Inactivation of gadd45a Sensitizes Epithelial Cancer Cells to Ionizing Radiation In vivo Resulting in Prolonged Survival.
X. Lu, C. Yang, R. Hill, C. Yin, M. C. Hollander, A. J. Fornace Jr, and T. Van Dyke (2008)
Cancer Res.
68, 3579-3583
|Abstract »|Full Text »|PDF »
Soft Tissue Sarcoma Cells Are Highly Sensitive to AKT Blockade: A Role for p53-Independent Up-regulation of GADD45{alpha}.
Q.-S. Zhu, W. Ren, B. Korchin, G. Lahat, A. Dicker, Y. Lu, G. Mills, R. E. Pollock, and D. Lev (2008)
Cancer Res.
68, 2895-2903
|Abstract »|Full Text »|PDF »
Transcription Factor FOXO3a Mediates Apoptosis in HIV-1-Infected Macrophages.
Molecular basis of the redox regulation of SUMO proteases: a protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation.
Z. Xu, L. S. M. Lam, L. H. Lam, S. F. Chau, T. B. Ng, and S. W. N. Au (2008)
FASEB J
22, 127-137
|Abstract »|Full Text »|PDF »
AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation.
W. Cai, J. C. He, L. Zhu, X. Chen, G. E. Striker, and H. Vlassara (2008)
Am J Physiol Cell Physiol
294, C145-C152
|Abstract »|Full Text »|PDF »
A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration.
E. Lara-Pezzi, N. Winn, A. Paul, K. McCullagh, E. Slominsky, M. P. Santini, F. Mourkioti, P. Sarathchandra, S. Fukushima, K. Suzuki, et al. (2007)
J. Cell Biol.
179, 1205-1218
|Abstract »|Full Text »|PDF »
Gone with the Wnts: {beta}-Catenin, T-Cell Factor, Forkhead Box O, and Oxidative Stress in Age-Dependent Diseases of Bone, Lipid, and Glucose Metabolism.
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.
C. Bouchard, S. Lee, V. Paulus-Hock, C. Loddenkemper, M. Eilers, and C. A. Schmitt (2007)
Genes & Dev.
21, 2775-2787
|Abstract »|Full Text »|PDF »
Complex N-Glycan and Metabolic Control in Tumor Cells.
R. Mendelsohn, P. Cheung, L. Berger, E. Partridge, K. Lau, A. Datti, J. Pawling, and J. W. Dennis (2007)
Cancer Res.
67, 9771-9780
|Abstract »|Full Text »|PDF »
The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor.
E. L. Greer, P. R. Oskoui, M. R. Banko, J. M. Maniar, M. P. Gygi, S. P. Gygi, and A. Brunet (2007)
J. Biol. Chem.
282, 30107-30119
|Abstract »|Full Text »|PDF »
Oxidative Stress Antagonizes Wnt Signaling in Osteoblast Precursors by Diverting beta-Catenin from T Cell Factor- to Forkhead Box O-mediated Transcription.
M. Almeida, L. Han, M. Martin-Millan, C. A. O'Brien, and S. C. Manolagas (2007)
J. Biol. Chem.
282, 27298-27305
|Abstract »|Full Text »|PDF »
Activation of FOXO3a by the Green Tea Polyphenol Epigallocatechin-3-Gallate Induces Estrogen Receptor {alpha} Expression Reversing Invasive Phenotype of Breast Cancer Cells.
K. Belguise, S. Guo, and G. E. Sonenshein (2007)
Cancer Res.
67, 5763-5770
|Abstract »|Full Text »|PDF »
FOXO Transcription Factors in the Regulatory Networks of Longevity.
Differential Regulation of Foxo3a Target Genes in Erythropoiesis.
W. J. Bakker, T. B. van Dijk, M. Parren-van Amelsvoort, A. Kolbus, K. Yamamoto, P. Steinlein, R. G. W. Verhaak, T. W. Mak, H. Beug, B. Lowenberg, et al. (2007)
Mol. Cell. Biol.
27, 3839-3854
|Abstract »|Full Text »|PDF »
The emerging role of FOXO transcription factors in pancreatic {beta} cells.
Inhibition of wild-type p66ShcA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype.
J. Chintapalli, S. Yang, D. Opawumi, S. R. Goyal, N. Shamsuddin, A. Malhotra, K. Reiss, and L. G. Meggs (2007)
Am J Physiol Renal Physiol
292, F523-F530
|Abstract »|Full Text »|PDF »
Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells.
C. Riou, B. Yassine-Diab, J. Van grevenynghe, R. Somogyi, L. D. Greller, D. Gagnon, S. Gimmig, P. Wilkinson, Y. Shi, M. J. Cameron, et al. (2007)
J. Exp. Med.
204, 79-91
|Abstract »|Full Text »|PDF »
A Novel Class of Vascular Endothelial Growth Factor-responsive Genes That Require Forkhead Activity for Expression.
Md. R. Abid, S.-C. Shih, H. H. Otu, K. C. Spokes, Y. Okada, D. T. Curiel, T. Minami, and W. C. Aird (2006)
J. Biol. Chem.
281, 35544-35553
|Abstract »|Full Text »|PDF »
Differential Expression of FOXO1 and FOXO3a Confers Resistance to Oxidative Cell Death upon Endometrial Decidualization.
T. Kajihara, M. Jones, L. Fusi, M. Takano, F. Feroze-Zaidi, G. Pirianov, H. Mehmet, O. Ishihara, J. M. Higham, E. W.-F. Lam, et al. (2006)
Mol. Endocrinol.
20, 2444-2455
|Abstract »|Full Text »|PDF »
IKK{beta}/2 induces TWEAK and apoptosis in mammary epithelial cells.
F. O. Baxter, P. J. Came, K. Abell, B. Kedjouar, M. Huth, K. Rajewsky, M. Pasparakis, and C. J. Watson (2006)
Development
133, 3485-3494
|Abstract »|Full Text »|PDF »
Intrinsic Kinase Activity and SQ/TQ Domain of Chk2 Kinase as Well as N-terminal Domain of Wip1 Phosphatase Are Required for Regulation of Chk2 by Wip1.
A. Yoda, X. Z. Xu, N. Onishi, K. Toyoshima, H. Fujimoto, N. Kato, I. Oishi, T. Kondo, and Y. Minami (2006)
J. Biol. Chem.
281, 24847-24862
|Abstract »|Full Text »|PDF »
A FoxO-Smad synexpression group in human keratinocytes.
R. R. Gomis, C. Alarcon, W. He, Q. Wang, J. Seoane, A. Lash, and J. Massague (2006)
PNAS
103, 12747-12752
|Abstract »|Full Text »|PDF »
Phosphatidylinositol 3-Kinase-dependent Suppression of the Human Inducible Nitric-oxide Synthase Promoter Is Mediated by FKHRL1.
A. S. Kristof, J. Fielhaber, A. Triantafillopoulos, S. Nemoto, and J. Moss (2006)
J. Biol. Chem.
281, 23958-23968
|Abstract »|Full Text »|PDF »
Effects of expression of p53 and Gadd45 on osmotic tolerance of renal inner medullary cells.
Q. Cai, N. I. Dmitrieva, J. D. Ferraris, L. F. Michea, J. M. Salvador, M. C. Hollander, A. J. Fornace Jr., R. A. Fenton, and M. B. Burg (2006)
Am J Physiol Renal Physiol
291, F341-F349
|Abstract »|Full Text »|PDF »
FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal.
H. You, M. Pellegrini, K. Tsuchihara, K. Yamamoto, G. Hacker, M. Erlacher, A. Villunger, and T. W. Mak (2006)
J. Exp. Med.
203, 1657-1663
|Abstract »|Full Text »|PDF »
Suppression of Lung Tumor Formation by the Regulatory Subunit of Ribonucleotide Reductase..
Glucose Regulates Foxo1 Through Insulin Receptor Signaling in the Pancreatic Islet {beta}-cell.
S. C. Martinez, C. Cras-Meneur, E. Bernal-Mizrachi, and M. A. Permutt (2006)
Diabetes
55, 1581-1591
|Abstract »|Full Text »|PDF »
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways..
M. Nyakern, A. Cappellini, I. Mantovani, and A. M. Martelli (2006)
Mol. Cancer Ther.
5, 1559-1570
|Abstract »|Full Text »|PDF »
Reactive Oxygen Species-Mediated Mitochondria-to-Nucleus Signaling: A Key to Aging and Radical-Caused Diseases.
Md. R. Abid, K. Yano, S. Guo, V. I. Patel, G. Shrikhande, K. C. Spokes, C. Ferran, and W. C. Aird (2005)
J. Biol. Chem.
280, 29864-29873
|Abstract »|Full Text »|PDF »
LY294002 and LY303511 Sensitize Tumor Cells to Drug-Induced Apoptosis via Intracellular Hydrogen Peroxide Production Independent of the Phosphoinositide 3-Kinase-Akt Pathway.
Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress.
A. B. Salmon, S. Murakami, A. Bartke, J. Kopchick, K. Yasumura, and R. A. Miller (2005)
Am J Physiol Endocrinol Metab
289, E23-E29
|Abstract »|Full Text »|PDF »
Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic {beta}-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression.
S.-J. Kim, K. Winter, C. Nian, M. Tsuneoka, Y. Koda, and C. H. S. McIntosh (2005)
J. Biol. Chem.
280, 22297-22307
|Abstract »|Full Text »|PDF »
Phosphorylation of p66Shc and forkhead proteins mediates A{beta} toxicity.
W. W. Smith, D. D. Norton, M. Gorospe, H. Jiang, S. Nemoto, N. J. Holbrook, T. Finkel, and J. W. Kusiak (2005)
J. Cell Biol.
169, 331-339
|Abstract »|Full Text »|PDF »
Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT Signaling.
X.-F. Le, A. Lammayot, D. Gold, Y. Lu, W. Mao, T. Chang, A. Patel, G. B. Mills, and R. C. Bast Jr. (2005)
J. Biol. Chem.
280, 2092-2104
|Abstract »|Full Text »|PDF »
Disruption of Yeast Forkhead-associated Cell Cycle Transcription by Oxidative Stress.
M. Shapira, E. Segal, and D. Botstein (2004)
Mol. Biol. Cell
15, 5659-5669
|Abstract »|Full Text »|PDF »
MUC1 Oncoprotein Activates the FOXO3a Transcription Factor in a Survival Response to Oxidative Stress.
p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1.
H. You, Y. Jang, A. I. You-Ten, H. Okada, J. Liepa, A. Wakeham, K. Zaugg, and T. W. Mak (2004)
PNAS
101, 14057-14062
|Abstract »|Full Text »|PDF »
Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control.
Y. Kamei, S. Miura, M. Suzuki, Y. Kai, J. Mizukami, T. Taniguchi, K. Mochida, T. Hata, J. Matsuda, H. Aburatani, et al. (2004)
J. Biol. Chem.
279, 41114-41123
|Abstract »|Full Text »|PDF »
Abnormal Angiogenesis in Foxo1 (Fkhr)-deficient Mice.
T. Furuyama, K. Kitayama, Y. Shimoda, M. Ogawa, K. Sone, K. Yoshida-Araki, H. Hisatsune, S.-i. Nishikawa, K. Nakayama, K. Nakayama, et al. (2004)
J. Biol. Chem.
279, 34741-34749
|Abstract »|Full Text »|PDF »
Insulin and IGF-I as determinants of low 'Western' cancer rates in the rural third world.
M. F McCarty (2004)
Int. J. Epidemiol.
33, 908-910
|Full Text »|PDF »
FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2SIRT1.
A. van der Horst, L. G. J. Tertoolen, L. M. M. de Vries-Smits, R. A. Frye, R. H. Medema, and B. M. T. Burgering (2004)
J. Biol. Chem.
279, 28873-28879
|Abstract »|Full Text »|PDF »
NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a.
T.-L. Gu, Z. Tothova, B. Scheijen, J. D. Griffin, D. G. Gilliland, and D. W. Sternberg (2004)
Blood
103, 4622-4629
|Abstract »|Full Text »|PDF »
Inside Insulin Signaling, Communication Is Key to Long Life.
Androgens Negatively Regulate Forkhead Transcription Factor FKHR (FOXO1) through a Proteolytic Mechanism in Prostate Cancer Cells.
H. Huang, D. C. Muddiman, and D. J. Tindall (2004)
J. Biol. Chem.
279, 13866-13877
|Abstract »|Full Text »|PDF »
Inhibition of Phosphorylation of a Forkhead Transcription Factor Sensitizes Human Ovarian Cancer Cells to Cisplatin.
E. Arimoto-Ishida, M. Ohmichi, S. Mabuchi, T. Takahashi, C. Ohshima, J. Hayakawa, A. Kimura, K. Takahashi, Y. Nishio, M. Sakata, et al. (2004)
Endocrinology
145, 2014-2022
|Abstract »|Full Text »|PDF »
Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase.
A. Brunet, L. B. Sweeney, J. F. Sturgill, K. F. Chua, P. L. Greer, Y. Lin, H. Tran, S. E. Ross, R. Mostoslavsky, H. Y. Cohen, et al. (2004)
Science
303, 2011-2015
|Abstract »|Full Text »|PDF »
Vascular Endothelial Growth Factor Activates PI3K/Akt/Forkhead Signaling in Endothelial Cells.
Md. R. Abid, S. Guo, T. Minami, K. C. Spokes, K. Ueki, C. Skurk, K. Walsh, and W. C. Aird (2004)
Arterioscler. Thromb. Vasc. Biol.
24, 294-300
|Abstract »|Full Text »
The Akt-regulated Forkhead Transcription Factor FOXO3a Controls Endothelial Cell Viability through Modulation of the Caspase-8 Inhibitor FLIP.
C. Skurk, H. Maatz, H.-S. Kim, J. Yang, M. R. Abid, W. C. Aird, and K. Walsh (2004)
J. Biol. Chem.
279, 1513-1525
|Abstract »|Full Text »|PDF »
Regulation of sterol carrier protein gene expression by the Forkhead transcription factor FOXO3a.
T. B. Dansen, G. J. P. L. Kops, S. Denis, N. Jelluma, R. J. A. Wanders, J. L. Bos, B. M. T. Burgering, and K. W. A. Wirtz (2004)
J. Lipid Res.
45, 81-88
|Abstract »|Full Text »|PDF »
FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines.
A. Sunters, S. Fernandez de Mattos, M. Stahl, J. J. Brosens, G. Zoumpoulidou, C. A. Saunders, P. J. Coffer, R. H. Medema, R. C. Coombes, and E. W.-F. Lam (2003)
J. Biol. Chem.
278, 49795-49805
|Abstract »|Full Text »|PDF »
Long-Term Treatment with Insulin Induces Apoptosis in Brown Adipocytes: Role of Oxidative Stress.
A. Porras, S. Zuluaga, A. Valladares, A. M. Alvarez, B. Herrera, I. Fabregat, and M. Benito (2003)
Endocrinology
144, 5390-5401
|Abstract »|Full Text »|PDF »
Insulin Inhibition of Transcription Stimulated by the Forkhead Protein Foxo1 Is Not Solely due to Nuclear Exclusion.
W.-C. Tsai, N. Bhattacharyya, L.-Y. Han, J. A. Hanover, and M. M. Rechler (2003)
Endocrinology
144, 5615-5622
|Abstract »|Full Text »|PDF »
Global Expression Analysis of Well-Differentiated Pancreatic Endocrine Neoplasms Using Oligonucleotide Microarrays.
A. Maitra, D. E. Hansel, P. Argani, R. Ashfaq, A. Rahman, A. Naji, S. Deng, J. Geradts, L. Hawthorne, M. G. House, et al. (2003)
Clin. Cancer Res.
9, 5988-5995
|Abstract »|Full Text »|PDF »
Farnesyltransferase inhibitors in hematologic malignancies: new horizons in therapy.
FoxO6, a Novel Member of the FoxO Class of Transcription Factors with Distinct Shuttling Dynamics.
F. M. J. Jacobs, L. P. van der Heide, P. J. E. C. Wijchers, J. P. H. Burbach, M. F. M. Hoekman, and M. P. Smidt (2003)
J. Biol. Chem.
278, 35959-35967
|Abstract »|Full Text »|PDF »
FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons.
FOXO Transcription Factors as Regulators of Immune Homeostasis: Molecules to Die for?.
K. U. Birkenkamp and P. J. Coffer (2003)
J. Immunol.
171, 1623-1629
|Full Text »|PDF »
Alterations of gene expression in failing myocardium following left ventricular assist device support.
Y. Chen, S. Park, Y. Li, E. Missov, M. Hou, X. Han, J. L. Hall, L. W. Miller, and R. J. Bache (2003)
Physiol Genomics
14, 251-260
|Abstract »|Full Text »|PDF »
Gadd45{gamma} Expression Is Reduced in Anaplastic Thyroid Cancer and Its Reexpression Results in Apoptosis.
H. K. Chung, Y.-W. Yi, N.-C. Jung, D. Kim, J. M. Suh, H. Kim, K. C. Park, D. W. Kim, E. S. Hwang, J. H. Song, et al. (2003)
J. Clin. Endocrinol. Metab.
88, 3913-3920
|Abstract »|Full Text »|PDF »
Characterization of Insulin Inhibition of Transactivation by a C-terminal Fragment of the Forkhead Transcription Factor Foxo1 in Rat Hepatoma Cells.
(2003)
Sci. Aging Knowl. Environ.
2003, tg4-4
|Full Text »
Expression of the Serum- and Glucocorticoid-inducible Protein Kinase, Sgk, Is a Cell Survival Response to Multiple Types of Environmental Stress Stimuli in Mammary Epithelial Cells.
M. L. L. Leong, A. C. Maiyar, B. Kim, B. A. O'Keeffe, and G. L. Firestone (2003)
J. Biol. Chem.
278, 5871-5882
|Abstract »|Full Text »|PDF »
How does calorie restriction work?.
J. Koubova and L. Guarente (2003)
Genes & Dev.
17, 313-321
|Full Text »|PDF »
Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage.
E. S. Kandel, J. Skeen, N. Majewski, A. Di Cristofano, P. P. Pandolfi, C. S. Feliciano, A. Gartel, and N. Hay (2002)
Mol. Cell. Biol.
22, 7831-7841
|Abstract »|Full Text »|PDF »
Phosphorylation of Serine 256 Suppresses Transactivation by FKHR (FOXO1) by Multiple Mechanisms. DIRECT AND INDIRECT EFFECTS ON NUCLEAR/CYTOPLASMIC SHUTTLING AND DNA BINDING.
X. Zhang, L. Gan, H. Pan, S. Guo, X. He, S. T. Olson, A. Mesecar, S. Adam, and T. G. Unterman (2002)
J. Biol. Chem.
277, 45276-45284
|Abstract »|Full Text »|PDF »
Prediction of Chemosensitivity for Patients with Acute Myeloid Leukemia, According to Expression Levels of 28 Genes Selected by Genome-wide Complementary DNA Microarray Analysis,.
J.-i. Okutsu, T. Tsunoda, Y. Kaneta, T. Katagiri, O. Kitahara, H. Zembutsu, R. Yanagawa, S. Miyawaki, K. Kuriyama, N. Kubota, et al. (2002)
Mol. Cancer Ther.
1, 1035-1042
|Abstract »|Full Text »|PDF »